RT Journal Article
SR Electronic
T1 Wearable Data Reveals distinct Characteristics of Individuals with Persistent Symptoms after a SARS-CoV-2 Infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.21.24307673
DO 10.1101/2024.05.21.24307673
A1 Ledebur, Katharina
A1 Wiedermann, Marc
A1 Puta, Christian
A1 Thurner, Stefan
A1 Klimek, Peter
A1 Brockmann, Dirk
YR 2024
UL http://medrxiv.org/content/early/2024/10/18/2024.05.21.24307673.abstract
AB Evidence on long-term health effects of SARS-CoV-2 infection remains scarce. Using a wearablederived behavioral and physiological dataset (n = 20,815), we identified 137 individuals characterized by self-reported persistent fatigue and shortness of breath following a SARS-CoV-2 infection. Compared with symptom-free COVID-19 positive and negative controls, these individuals had higher resting heart rates (mean difference 2.37/1.49 bpm) and lower daily step counts (mean 3,030/2,909 steps fewer), even at least three weeks prior to SARS-CoV-2 infection. In addition, persistent COVID-19 symptoms were associated with a significant reduction in mean quality of life (WHO-5, EQ-5D), even before infection. Analysis of individual wearable time series suggests that individuals with persistent symptoms may have been more exposed to pre-existing health conditions/lower fitness levels prior to SARS-CoV-2 infection. Our study demonstrates the potential of wearable devices to track physiological and physical activity dynamics under natural conditions in the context of infectious and chronic diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded in part with funds from the funding program of the City of Vienna MA7 with no role of the study sponsor in study design, collection, analysis, interpretation of the data, writing of the report and decision to submit.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participation in the study was voluntary and self-recruited. All individuals participating in the Corona Data Donation Project provided informed consent electronically via the app. Consent was provided separately for submitting vital data and participating in the in-app surveys. Participation is only possible for German residents age 16 and older and data is only stored pseudonymously, using a randomly generated unique user ID. Participant age is rounded to 5 years. The study is subject to strict compliance with the data protection provisions set out in the EU General Data Protection Regulation (GDPR) and the Federal Data Protection Act (BDSG). A comprehensive privacy impact assessment was conducted through an external law-firm specialized in e-Health and research projects. The study was reviewed and approved by the Data Privacy Officer at the Robert Koch Institute (internal operation number 2021-009) in agreement with the Federal Commissioner for Data Protection and Freedom of Information (BfDI), Germany's highest independent supreme federal authority for data protection and freedom of information. Ethical approval for this study was obtained from the ethics board at the University of Erfurt (approval number 20220414).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes